BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10714605)

  • 1. Transdermal delivery of macromolecules using skin electroporation.
    Lombry C; Dujardin N; Préat V
    Pharm Res; 2000 Jan; 17(1):32-7. PubMed ID: 10714605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal drug delivery by in-skin electroporation using a microneedle array.
    Yan K; Todo H; Sugibayashi K
    Int J Pharm; 2010 Sep; 397(1-2):77-83. PubMed ID: 20619329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal delivery of macromolecules by erbium:YAG laser.
    Fang JY; Lee WR; Shen SC; Wang HY; Fang CL; Hu CH
    J Control Release; 2004 Nov; 100(1):75-85. PubMed ID: 15491812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of calcium chloride and sodium chloride on the electroporation-mediated skin permeation of fluorescein isothiocyanate (FITC)-dextrans in vitro.
    Tokudome Y; Sugibayashi K
    Biol Pharm Bull; 2003 Oct; 26(10):1508-10. PubMed ID: 14519966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the enhancement effect of n-octyl-beta-D-thioglucoside on the transdermal penetration of fluorescein isothiocyanate-labeled dextrans and the molecular weight dependence of water-soluble penetrants through stripped skin.
    Ogiso T; Paku T; Iwaki M; Tanino T
    J Pharm Sci; 1994 Dec; 83(12):1676-81. PubMed ID: 7534349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transdermal transport by electroporation using anionic lipids.
    Sen A; Zhao Y; Zhang L; Hui SW
    J Control Release; 2002 Aug; 82(2-3):399-405. PubMed ID: 12175752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
    Ito Y; Ise A; Sugioka N; Takada K
    Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant-enhanced transdermal delivery by electroporation.
    Murthy SN; Sen A; Hui SW
    J Control Release; 2004 Aug; 98(2):307-15. PubMed ID: 15262421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pulse duration, power and energy of fractional Er:YAG laser for transdermal delivery of differently sized FITC dextrans.
    Zorec B; Škrabelj D; Marinček M; Miklavčič D; Pavšelj N
    Int J Pharm; 2017 Jan; 516(1-2):204-213. PubMed ID: 27818244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypsin as a novel potential absorption enhancer for improving the transdermal delivery of macromolecules.
    Li YZ; Quan YS; Zang L; Jin MN; Kamiyama F; Katsumi H; Tsutsumi S; Yamamoto A
    J Pharm Pharmacol; 2009 Aug; 61(8):1005-12. PubMed ID: 19703343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal drug delivery enhanced by low voltage electropulsation (LVE).
    Sammeta SM; Vaka SR; Murthy SN
    Pharm Dev Technol; 2009; 14(2):159-64. PubMed ID: 19519188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combination of microneedles with electroporation and sonophoresis to enhance hydrophilic macromolecule skin penetration.
    Petchsangsai M; Rojanarata T; Opanasopit P; Ngawhirunpat T
    Biol Pharm Bull; 2014; 37(8):1373-82. PubMed ID: 24931312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.
    Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Yuan CY; Fang JY
    J Control Release; 2011 Aug; 153(3):240-8. PubMed ID: 21435360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation pathway of macromolecules and nanospheres through skin.
    Todo H; Kimura E; Yasuno H; Tokudome Y; Hashimoto F; Ikarashi Y; Sugibayashi K
    Biol Pharm Bull; 2010; 33(8):1394-9. PubMed ID: 20686237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macromolecules as novel transdermal transport enhancers for skin electroporation.
    Vanbever R; Prausnitz MR; Préat V
    Pharm Res; 1997 May; 14(5):638-44. PubMed ID: 9165536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macromolecular delivery into skin using a hollow microneedle.
    Wonglertnirant N; Todo H; Opanasopit P; Ngawhirunpat T; Sugibayashi K
    Biol Pharm Bull; 2010; 33(12):1988-93. PubMed ID: 21139238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of macromolecules into synaptosomes using electroporation.
    Ramanathan M; Kuo HR; Lambert CW; Ingoglia NA
    J Neurosci Methods; 2000 Mar; 96(1):19-23. PubMed ID: 10704667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran.
    Wu XM; Todo H; Sugibayashi K
    Int J Pharm; 2006 Jun; 316(1-2):102-8. PubMed ID: 16597490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation.
    Regnier V; Préat V
    Pharm Res; 1998 Oct; 15(10):1596-602. PubMed ID: 9794503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.